CVS Health Corporation (CVS)

[DiscoverGold]

CVS Health Co. Forecasted to Post Q2 2021 Earnings of $1.87 Per Share (NYSE:CVS)
By: MarketBeat | February 1, 2021

CVS Health Co. (NYSE:CVS) - Research analysts at Oppenheimer lowered their Q2 2021 earnings estimates for shares of CVS Health in a report released on Wednesday, January 27th. Oppenheimer analyst M. Wiederhorn now anticipates that the pharmacy operator will post earnings per share of $1.87 for the quarter, down from their previous forecast of $1.98. Oppenheimer also issued estimates for CVS Health's Q3 2021 earnings at $1.90 EPS, Q1 2022 earnings at $1.89 EPS, Q2 2022 earnings at $2.09 EPS, Q3 2022 earnings at $2.06 EPS, Q4 2022 earnings at $2.13 EPS and FY2022 earnings at $8.18 EPS. CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 11th. The pharmacy operator reported $1.66 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.33 by $0.33. CVS Health had a net margin of 2.99% and a return on equity of 15.60%. The firm had revenue of $67.05 billion for the quarter, compared to the consensus estimate of $66.54 billion. During the same period in the prior year, the firm earned $1.84 EPS. The company's revenue was up 3.5% compared to the same quarter last year.

Several other analysts also recently commented on the stock. Cantor Fitzgerald reissued an "overweight" rating on shares of CVS Health in a research report on Monday, November 9th. Piper Sandler increased their price objective on shares of CVS Health from $72.00 to $76.00 and gave the company an "overweight" rating in a research report on Wednesday, November 11th. Jefferies Financial Group upgraded shares of CVS Health from a "hold" rating to a "buy" rating and set a $90.00 target price on the stock in a research note on Friday, January 8th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CVS Health from $104.00 to $101.00 and set a "buy" rating on the stock in a research note on Monday, November 9th. Finally, SVB Leerink upped their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a "market perform" rating in a research note on Monday, December 14th. Three investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company's stock. CVS Health presently has an average rating of "Buy" and a consensus price target of $82.93.

Read Full Story »»»

DiscoverGold